Clinical

Dataset Information

Phase I/II Trial of Regorafenib, Hydroxychloroquine, and Entinostat in Metastatic Colorectal Cancer


ABSTRACT: The main purpose of this study is to find the best dose of hydroxychloroquine (HCQ) when given in combination with regorafenib and entinostat.

DISEASE(S): Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2249147 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR